Title
Department of Health vs. Philippine Tobacco Institute, Inc.
Case
G.R. No. 200431
Decision Date
Jul 13, 2021
Philippine Supreme Court upheld FDA's authority to regulate tobacco as health products, rejecting claims of exclusive IAC-Tobacco jurisdiction under RA 9211.
A

Case Digest (G.R. No. 200431)

Facts:

  • Evolution of the FDA and IRR
    • 1963: RA 3720 creates Food and Drug Administration under DOH.
    • 1982–1987: Bureau abolished, functions transferred; EO 175 amends RA 3720.
    • 2009: RA 9711 renames Bureau as FDA, expands to all health products; Sec. 22 directs DOH-FDA to issue IRR within 120 days.
    • 2011: DOH-FDA issues Implementing Rules including classification of tobacco as “health products.”
  • Litigation over tobacco regulation
    • PTI files declaratory-injunction petition in RTC, challenging IRR as beyond RA 9711 and contrary to RA 9211 (Tobacco Regulation Act) and IAC-Tobacco’s exclusive jurisdiction.
    • RTC (Branch 255, Jan 27 2012) voids IRR provisions on tobacco, ruling RA 9711 excludes tobacco and defers to IAC-Tobacco under RA 9211.
    • DOH-FDA petitions SC for certiorari; PTI, Senators Cayetano/Drilon, and Rep. Lagman intervene.
    • Legislative and treaty context: WHO FCTC ratified (2005), various DOH memos and AO’s on tobacco industry interference, RA 10351 (Sin Tax), RA 10643 (Graphic Health Warnings).

Issues:

  • Whether Sec. 25 of RA 9711 excludes regulation of health aspects of tobacco products from FDA authority.
  • Whether tobacco products qualify as “health products” under Sec. 10(ff) of RA 3720, as amended by RA 9711.

Ruling:

  • (Subscriber-Only)

Ratio:

  • (Subscriber-Only)

Doctrine:

  • (Subscriber-Only)

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.